Dr Sarah Pett

Aichelburg A; Pett SL; Cooper DA, 2002, 'AIDS: Understanding HIV Transmission', in Encyclopedia of World Sciences, edn. Original, MacMillan Publishers, www.els.net, pp. 1 - 6

Castillo-Mancilla JR; Phillips AN; Neaton JD; Neuhaus J; Sharma S; Baker JV; Collins S; Mannheimer S; Pett S; Touzeau-Römer V; Polizzotto MN; Lundgren JD; Gardner EM, 2019, 'Incomplete ART adherence is associated with higher inflammation in individuals who achieved virologic suppression in the START study', Journal of the International AIDS Society, vol. 22, http://dx.doi.org/10.1002/jia2.25297

Kityo C; Szubert AJ; Siika A; Heyderman R; Bwakura-Dangarembizi M; Lugemwa A; Mwaringa S; Griffiths A; Nkanya I; Kabahenda S; Wachira S; Musoro G; Rajapakse C; Etyang T; Abach J; Spyer MJ; Wavamunno P; Nyondo-Mipando L; Chidziva E; Nathoo K; Klein N; Hakim J; Gibb DM; Walker AS; Pett SL, 2018, 'Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial', PLoS Medicine, vol. 15, pp. e1002706, http://dx.doi.org/10.1371/journal.pmed.1002706

Vanderven HA; Wragg K; Ana-Sosa-Batiz F; Kristensen AB; Jegaskanda S; Wheatley AK; Wentworth D; Wines BD; Hogarth PM; Rockman S; Kent SJ; Emery S; Lane HC; Amin J; Davey RT; Markowitz NP; Pett SL; Beigel J; Gardner E; Temesgen Z, 2018, 'Anti-Influenza Hyperimmune Immunoglobulin Enhances Fc-Functional Antibody Immunity During Human Influenza Infection', The Journal of Infectious Diseases, vol. 218, pp. 1383 - 1393, http://dx.doi.org/10.1093/infdis/jiy328

Simonsen L; Higgs E; Taylor RJ; Wentworth D; Cozzi-Lepri A; Pett S; Dwyer DE; Davey R; Lynfield R; Losso M; Morales K; Glesby MJ; Weckx J; Carey D; Lane C; Lundgren J, 2018, 'Using clinical research networks to assess severity of an emerging influenza pandemic', Clinical Infectious Diseases, vol. 67, pp. 341 - 349, http://dx.doi.org/10.1093/cid/ciy088

Mallewa J; Szubert AJ; Mugyenyi P; Chidziva E; Thomason MJ; Chepkorir P; Abongomera G; Baleeta K; Etyang A; Warambwa C; Melly B; Mudzingwa S; Kelly C; Agutu C; Wilkes H; Nkomani S; Musiime V; Lugemwa A; Pett SL; Bwakura-Dangarembizi M; Prendergast AJ; Gibb DM; Walker AS; Berkley JA; Kityo C; Wavamunno P; Nambi E; Ocitti P; Ndigendawani M; Kabahenda S; Kemigisa M; Acen J; Olebo DF; Mpamize G; Amone A; Okweny D; Mbonye A; Nambaziira F; Rweyora A; Kangah M; Kabaswahili B; Abach J; Omongin J; Aciro I; Philliam A; Arach B; Ocung E; Amone G; Miles P; Adong C; Tumsuiime C; Kidega P; Otto B; Apio F; Mukuye A; Abwola M; Ssennono F; Baliruno D; Tuhirwe S; Namisi R; Kigongo F; Kikyonkyo D; Mushahara F; Tusiime J; Musiime A; Nankya A; Atwongyeire D; Sirikye S; Myalo S; Noowe N; Kasozi M; Mwebe S; Atwine L; Senkindu T; Natuhurira I; Katemba C; Ninsiima E; Acaku M; Kyomuhangi J; Ankunda R; Tukwasibwe D; Ayesiga L; Hakim J; Nathoo K; Reid A; Mhute T; Tinago G; Bhiri J; Phiri M; Steamer J; Nhema R; Musoro G; Mutsai S; Nemasango B; Moyo C; Chitongo S; Rashirai K; Vhembo S; Mlambo B; Ndemera B, 2018, 'Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trial', The Lancet HIV, vol. 5, pp. e231 - e240, http://dx.doi.org/10.1016/S2352-3018(18)30038-9

Post FA; Szubert AJ; Prendergast AJ; Johnston V; Lyall H; Fitzgerald F; Musiime V; Musoro G; Chepkorir P; Agutu C; Mallewa J; Rajapakse C; Wilkes H; Hakim J; Mugyenyi P; Sarah Walker A; Gibb DM; Pett SL; Kityo C; Wavamunno P; Nambi E; Ocitti P; Ndigendawani M; Portal F; Kabahenda S; Kemigisa M; Acen J; Olebo D; Mpamize G; Amone A; Okweny D; Mbonye A; Nambaziira F; Rweyora A; Kangah M; Kabaswahili V; Abach J; Abongomera G; Omongin J; Aciro I; Philliam A; Arach B; Ocung E; Amone G; Miles P; Adong C; Tumsuiime C; Kidega P; Otto B; Apio F; Baleeta K; Mukuye A; Abwola M; Ssennono F; Baliruno D; Tuhirwe S; Namisi R; Kigongo F; Kikyonkyo D; Mushahara F; Tusiime J; Musiime A; Nankya A; Atwongyeire D; Sirikye S; Mula S; Noowe N; Lugemwa A; Kasozi M; Mwebe S; Atwine L; Senkindu T; Natuhurira T; Katemba C; Ninsiima E; Acaku M; Kyomuhangi J; Ankunda R; Tukwasibwe D; Ayesiga L; Nathoo K; Bwakura-Dangarembizi M; Reid A; Chidziva E; Mhute T; Tinago GC; Bhiri J; Mudzingwa S; Phiri M; Steamer J; Nhema R; Warambwa C; Mutsai S; Nemasango B; Moyo C; Chitongo S; Rashirai K; Vhembo S; Mlambo B; Nkomani S, 2018, 'Causes and Timing of Mortality and Morbidity among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial', Clinical Infectious Diseases, vol. 66, pp. S132 - S139, http://dx.doi.org/10.1093/cid/cix1141

Powers JH; Bacci ED; Leidy NK; Poon JL; Stringer S; Memoli MJ; Han A; Fairchok MP; Coles C; Owens J; Chen WJ; Arnold JC; Danaher PJ; Lalani T; Burgess TH; Millar EV; Ridore M; Hernández A; Rodríguez-Zulueta P; Ortega-Gallegos H; Galindo-Fraga A; Ruiz-Palacios GM; Pett S; Fischer W; Gillor D; Macias LM; DuVal A; Rothman R; Dugas A; Guerrero ML, 2018, 'Performance of the inFLUenza Patient-Reported Outcome (FLU-PRO) diary in patients with influenza-like illness (ILI)', PLoS ONE, vol. 13, http://dx.doi.org/10.1371/journal.pone.0194180

Powers JH; Bacci ED; Guerrero ML; Leidy NK; Stringer S; Kim K; Memoli MJ; Han A; Fairchok MP; Chen WJ; Arnold JC; Danaher PJ; Lalani T; Ridoré M; Burgess TH; Millar EV; Hernández A; Rodríguez-Zulueta P; Smolskis MC; Ortega-Gallegos H; Pett S; Fischer W; Gillor D; Macias LM; DuVal A; Rothman R; Dugas A; Ruiz-Palacios GM, 2018, 'Reliability, Validity, and Responsiveness of InFLUenza Patient-Reported Outcome (FLU-PRO©) Scores in Influenza-Positive Patients', Value in Health, vol. 21, pp. 210 - 218, http://dx.doi.org/10.1016/j.jval.2017.04.014

Pett SL; Amin J; Horban A; Andrade-Villanueva J; Losso M; Porteiro N; Madero JS; Belloso W; Tu E; Silk D; Kelleher A; Harrigan R; Clark A; Sugiura W; Wolff M; Gill J; Gatell J; Clarke A; Ruxrungtham K; Prazuck T; Kaiser R; Woolley I; Alberto Arnaiz J; Cooper D; Rockstroh JK; Mallon P; Emery S; Fisher M; Rockstroh J; Stellbrink J; Merlin K; Yeung J; Fsadni B; Marks K; Suzuki K; Rismanto N; Salomon H; Rubio AE; Chibo D; Birch C; Swenson L; Chan D; Berg T; Obermeier M; Schuelter E; Aragon SS; Luebke N; Coughlan S; Dean J; Iwatani Y; Teran GR; Avila S; Sirivichayakul S; Naphassanant M; Ubolyam S; Kaye S; Land S; Walker S; Haubrich R; DeJesus E; Berthon-Jones N; Espinosa N; Courtney-Vega K; Absar N; Haskelberg H; Robson R; Donaldson A; Guelman D; Gambardella L; Valdovinos M; Arnaiz J; Beleta H; Ramos N; Targa M; Späth B; Boesecke C; Engelhardt A; Perry N; Beckthold B; Drummond F; Lefevre E; Corr S; Grant C; Lupo S; Peroni L; Sanchez M; De Paz Sierra M; Viloria G; Parlante A; Bissio E; Luchetti P; Confalonieri V; Warley E; Vieni I; Vilas C; Zarate A; Mayer G; Elliot J; Hagenauer M; Kelley M, 2018, 'Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) study', HIV Medicine, vol. 19, pp. 65 - 71, http://dx.doi.org/10.1111/hiv.12532

Pett SL; Kunisaki KM; Wentworth D; Griffin TJ; Kalomenidis I; Nahra R; Sanchez RM; Hodgson SW; Ruxrungtham K; Dwyer D; Davey RT; Wendt CH; Lundgren J; Jansson P; Pearson M; Aagaard B; Hudson F; Bennet R; Pacciarini F; Angus B; Paton N; Collaco Moraes Y; Cooper D; Emery S; Courtney-Rogers D; Robson R; Gordin F; Sanchez A; Standridge B; Vjecha M; Moricz A; Delfino M; Belloso W; Losso M; Tillmann K; Touloumi G; Gioukari V; Anagnostou O; La Rosa A; Saenz MJ; Lopez P; Herrero P; Portas B; Kaewon P; Ubolyam S; Brekke K; Campbell M; Denning E; DuChene A; Engen N; George M; Harrison M; Neaton JD; Nelson R; Quan SF; Schultz T; Baxter J; Brown S; Hoover M; Beigel J; Dewar R; Gover E; McConnell R; Metcalf J; Natarajan V; Rehman T; Voell J; Dwyer DE; Kok J; Uyeki T; Munroe D; Paez A; Bertrand M; Temesgen Z; Rizza S; Wolfe C; Carbonneau J; Novak R; Schwarber M; Polenakovik H; Clark L; Patil N; Riska P; Omotosho J; Faber L; Markowitz N; Glesby M; Ham K; Parenti D; Simon G; Coburn P; Freiberg M; Koerbel G; Dharan N; Paez-Quinde M; Gunter J; Beilke M; Lu Z; Gunderson E; Baker J, 2018, 'Increased indoleamine-2,3-dioxygenase activity is associated with poor clinical outcome in adults hospitalized with influenza in the INSIGHT FLU003Plus study', Open Forum Infectious Diseases, vol. 5, http://dx.doi.org/10.1093/ofid/ofx228

Castillo-Mancilla JR; Phillips AN; Neaton JD; Neuhaus J; Collins S; Mannheimer S; Pett S; Touzeau-Römer V; Polizzotto MN; Lundgren JD; Gardner EM, 2018, 'Association of Suboptimal Antiretroviral Therapy Adherence with Inflammation in Virologically Suppressed Individuals Enrolled in the SMART Study', Open Forum Infectious Diseases, vol. 5, http://dx.doi.org/10.1093/ofid/ofx275

Peterson RL; Vock DM; Powers JH; Emery S; Cruz EF; Hunsberger S; Jain MK; Pett S; Neaton JD, 2017, 'Analysis of an ordinal endpoint for use in evaluating treatments for severe influenza requiring hospitalization', Clinical Trials, vol. 14, pp. 264 - 276, http://dx.doi.org/10.1177/1740774517697919

Kelly ML; Pinto AN; Suan D; Marriott D; Cooper DA; Pett SL, 2017, 'Managing two decades of visceral leishmaniasis and HIV co-infection: A case report that illustrates the urgent research needs in the field', Sexual Health, vol. 14, pp. 286 - 288, http://dx.doi.org/10.1071/SH16036

Fox-Lewis A; Brima N; Muniina P; Grant AD; Edwards SG; Miller RF; Pett SL, 2016, 'Tuberculosis screening in patients with HIV: An audit against UK national guidelines to assess current practice and the effectiveness of an electronic tuberculosis-screening prompt', International Journal of STD and AIDS, vol. 27, pp. 901 - 905, http://dx.doi.org/10.1177/0956462416628355

Ryder S; Pett S; Cooke GS, 2016, 'Genotype 4 and the global challenge of hepatitis C treatment', The Lancet Gastroenterology and Hepatology, vol. 1, pp. 3 - 4, http://dx.doi.org/10.1016/S2468-1253(16)30006-1

Pett SL; Amin J; Horban A; Andrade-Villanueva J; Losso M; Porteiro N; Madero JS; Belloso W; Tu E; Silk D; Kelleher A; Harrigan R; Clark A; Sugiura W; Wolff M; Gill J; Gatell J; Fisher M; Clarke A; Ruxrungtham K; Prazuck T; Kaiser R; Woolley I; Arnaiz JA; Cooper D; Rockstroh JK; Mallon P; Emery S, 2016, 'Maraviroc, as a switch option, in HIV-1-infected individuals with stable, well-controlled HIV replication and R5-tropic virus on their first Nucleoside/Nucleotide reverse transcriptase inhibitor plus ritonavir-boosted protease inhibitor regimen: Week 48 Results of the randomized, multicenter March study', Clinical Infectious Diseases, vol. 63, pp. 122 - 132, http://dx.doi.org/10.1093/cid/ciw207

Murray DD; Suzuki K; Law M; Trebicka J; Neuhaus J; Wentworth D; Johnson M; Vjecha MJ; Kelleher AD; Emery S; Aagaard B; Aragon E; Arnaiz J; Borup L; Clotet B; Dragsted U; Fau A; Gey D; Grarup J; Hengge U; Herrero P; Jansson P; Jensen B; Jensen K; Juncher H; Lopez P; Lundgren JD; Matthews C; Mollerup D; Pearson M; Phillips A; Reilev S; Tillmann K; Varea S; Angus B; Babiker A; Cordwell B; Darbyshire J; Dodds W; Fleck S; Horton J; Hudson F; Moraes Y; Pacciarini F; Palfreeman A; Paton N; Smith N; Van Hooff F; Bebchuk J; Collins G; Denning E; DuChene A; Fosdick L; Harrison M; Herman-Lamin K; Krum E; Larson G; Neaton J; Nelson R; Quan K; Quan S; Schultz T; Thompson G; Wyman N; Carey C; Chan F; Cooper D; Courtney-Rodgers D; Drummond F; Harrod M; Jacoby S; Kearney L; Lin E; Pett S; Robson R; Seneviratne N; Stewart M; Watts E; Finley E; Gordin F; Sánchez A; Standridge B; Belloso W; Davey R; Duprez D; Gatell J; Hoy J; Lifson A; Pederson C; Perez G; Price R; Prineas R; Rhame F; Sampson J; Worley J; Modlin J; Beral V; Chaisson R; Fleming T; Hill C, 2015, 'Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection: A case control study', PLoS ONE, vol. 10, http://dx.doi.org/10.1371/journal.pone.0139981

Amin J; Becker S; Belloso W; Boffito M; Cooper D; Crabtree-Ramirez B; Duncombe C; Foulkes S; Hill A; Jessen H; Kumar S; Lee MP; Nwizu C; Read T; Rooney J; Schaffer K; Shahar E; Winston A; Wolff M; Young B; Abela C; Avihingsanon A; Boyd M; Carey D; Clarke A; Courtney-Vega K; Delfino M; Donaldson A; Emery S; Espinosa N; Johannesen T; Lin E; Losso M; Moricz A; Pett S; Phanupak P; Puls R; Pussadee K; Sutheerasak P; Tomlins L; Ubolyam S; bin Raja Azwa RIS; Bissio E; Calanni L; Chetchotisakd P; Doong N; Elliott J; Gazzard B; Kelly M; Laplume H; del Carmen Luna N; Lupo S; Messina OG; Mohapi L; Moore R; Nolan D; Orrell C; Perez C; Phanuphak P; Rockstroh J; Rowling D; Supparatpinyo K; Smith D; Villanueva JA; Vlahakis E; Kelleher T; Cunningham P; Merlin K; Yeung J; Shaik A; Fsadni B; Carrera A; Lograsso M; Gulick R; Dunn D; Dolan M, 2015, 'Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study', The Lancet Infectious Diseases, vol. 15, pp. 793 - 802, http://dx.doi.org/10.1016/S1473-3099(15)70060-5

Lundgren J; Babiker A; Gordin F; Emery S; Fätkenheuer G; Molina JM; Wood R; Neaton JD; Agan BK; Alston-Smith B; Arenas-Pinto A; Arribas JR; Baker JV; Baxter J; Belloso WH; Brekke K; Brew B; Brobst SW; Burman W; Carey C; Clark R; Cooper DA; Davey RT; De La Rosa G; Denning ET; Dolan M; Dore G; Duprez D; Emanuel E; Grady C; Grund B; Hirschel B; Hoen B; Hudson F; Johnson MA; Kambili C; Klingman K; Kunisaki KM; Landay A; Ledergerber B; Lehrman SN; Martinez A; Meger S; Misar K; Mitsuyasu RT; Mocroft A; Munroe D; Norton M; Palmer RC; Pett SL; Phillips A; Pillay D; Porter D; Price RW; Proschan M; Rappoport C; Reiss P; Renjifo B; Robertson K; Rockstroh J; Rodriguez G; Rooney JF; Ross MJ; Schechter M; Schwarze S; Seekins D; Sharma S; Snowden W; Telenti A; Tryon J; van Wyk J; Vjecha MJ; Wright E, 2015, 'Why START? Reflections that led to the conduct of this large long-term strategic HIV trial', HIV Medicine, vol. 16, pp. 1 - 9, http://dx.doi.org/10.1111/hiv.12227

Mocroft A; Lundgren JD; Ross M; Law M; Reiss P; Kirk O; Smith C; Wentworth D; Neuhaus J; Fux CA; Moranne O; Morlat P; Johnson MA; Ryom L; Powderly B; Shortman N; Moecklinghoff C; Reilly G; Franquet X; Sabin CA; Phillips A; Weber R; Pradier C; d'Arminio Monforte A; Dabis F; El-Sadr WM; De Wit S; Kamara D; Tverland J; Mansfeld M; Nielsen J; Raben D; Salbøl Brandt R; Rickenbach M; Fanti I; Krum E; Hillebregt M; Geffard S; Sundström A; Delforge M; Fontas E; Torres F; McManus H; Wright S; Kjær J; Sjøl A; Meidahl P; Helweg-Larsen J; Schmidt Iversen J; Kesselring AM; Friis-Møller N; Kowalska J; Sabin C; Bruyand M; Kamara DA; Bower M; Fätkenheuer G; Donald A; Grulich A; Prins JM; Kuijpers TW; Scherpbier HJ; van der Meer JTM; Wit FWMN; Godfried MH; van der Poll T; Nellen FJB; Geerlings SE; van Vugt M; Pajkrt D; Bos JC; Wiersinga WJ; van der Valk M; Goorhuis A; Hovius JW; van Eden J; Henderiks A; van Hes AMH; Mutschelknauss M; Nobel HE; Pijnappel FJJ; Westerman AM; Jurriaans S; Back NKT; Zaaijer HL; Berkhout B; Cornelissen MTE; Schinkel CJ; Thomas XV; van den Berge M; Stegeman A; Baas S; Hage de Looff L; Versteeg D; Pronk MJH; Ammerlaan HSM; Korsten-Vorstermans EMHM; de Munnik ES; Jansz AR; Tjhie J, 2015, 'Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study', PLoS Medicine, vol. 12, http://dx.doi.org/10.1371/journal.pmed.1001809

Madhavi V; Ana-Sosa-Batiz FE; Jegaskanda S; Center RJ; Winnall WR; Parsons MS; Ananworanich J; Cooper DA; Kelleher AD; Hsu D; Pett S; Stratov I; Kramski M; Kent SJ, 2015, 'Antibody-dependent effector functions against HIV decline in subjects receiving antiretroviral therapy', Journal of Infectious Diseases, vol. 211, pp. 529 - 538, http://dx.doi.org/10.1093/infdis/jiu486

Borges ÁH; O'Connor JL; Phillips AN; Rönsholt FF; Pett S; Vjecha MJ; French MA; Lundgren JD, 2015, 'Factors Associated with Plasma IL-6 Levels during HIV Infection', Journal of Infectious Diseases, vol. 212, pp. 585 - 595, http://dx.doi.org/10.1093/infdis/jiv123

Jackson Y; Pinto A; Pett S, 2014, 'Chagas disease in Australia and New Zealand: Risks and needs for public health interventions', Tropical Medicine and International Health, vol. 19, pp. 212 - 218, http://dx.doi.org/10.1111/tmi.12235

Hsu DC; Kerr SJ; Thongpaeng P; Iampornsin T; Pett SL; Zaunders JJ; Avihingsanon A; Ubolyam S; Ananworanich J; Kelleher AD; Cooper DA, 2014, 'Incomplete restoration of Mycobacterium tuberculosis-specific-CD4 T cell responses despite antiretroviral therapy', Journal of Infection, vol. 68, pp. 344 - 354, http://dx.doi.org/10.1016/j.jinf.2013.11.016

Phetsouphanh C; Xu Y; Bailey M; Pett S; Zaunders J; Seddiki N; Kelleher AD, 2014, 'Ratios of effector to central memory antigen-specific CD4 + T cells vary with antigen exposure in HIV+ patients', Immunology and Cell Biology, vol. 92, pp. 384 - 388, http://dx.doi.org/10.1038/icb.2013.101

Seddiki N; Cook L; Hsu DC; Phetsouphanh C; Brown K; Xu Y; Kerr SJ; Cooper DA; Munier CML; Pett S; Ananworanich J; Zaunders J; Kelleher AD, 2014, 'Human antigen-specific CD4⁺CD25⁺CD134⁺CD39⁺ T cells are enriched for regulatory T cells and comprise a substantial proportion of recall responses', European Journal of Immunology, vol. 44, pp. 1644 - 1661, http://dx.doi.org/10.1002/eji.201344102

Pinto A; Pett S; Jackson Y, 2014, 'Identifying chagas disease in Australia: An emerging challenge for general practitioners', Australian Family Physician, vol. 43, pp. 440 - 442

Amin J; Becker S; Belloso W; Boffito M; Cooper D; Crabtree-Ramirez B; Duncombe C; Emery S; Foulkes S; Hill A; Jessen H; Kumar S; Lee MP; Losso M; Nwizu C; Phanuphak P; Ripin D; Read T; Rooney J; Schaffer K; Shahar E; Winston A; Wolff M; Young B; Abela C; Boyd M; Carey D; Clarke A; Courtney-Vega K; Dazo C; Delfino M; Donaldson A; Espinosa N; Johannesen T; Kaew-On P; Lin E; Moricz A; Taylor J; Phanupak P; Puls RL; Pussadee K; Sutheerasak P; Tomkins L; Ubolyam S; Shah Bin Raja Azwa RI; Bissio E; Calanni L; Casiro A; Chetchotisakd P; Contarelli J; Doong N; Elliott J; Gazzard B; Kelly M; Del Carmen Luna N; Lupo S; Messina OG; Mohapi L; Moore R; Nolan D; Orrell C; Perez C; Pett S; Rockstroh J; Supparatpinyo K; Smith D; Villanueva JA; Vlahakis E; Kelleher T; Cunningham P; Merlin K; Yeung J; Shaik A; Fsadni B; Carrera A; Lograsso M; Gulick R; Crabtree-Ramiraz B; Winston E; Dunn D; Dolan M, 2014, 'Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): A randomised, double-blind, placebo-controlled, non-inferiority trial', The Lancet, vol. 383, pp. 1474 - 1482, http://dx.doi.org/10.1016/S0140-6736(13)62187-X

Borges AH; O'Connor JL; Phillips AN; Rönsholt FF; Pett S; Vjecha MJ; French MA; Lundgren JD, 2014, 'Determinants of IL-6 levels during HIV infection.', J Int AIDS Soc, vol. 17, pp. 19482, http://dx.doi.org/10.7448/IAS.17.4.19482

Hsu DC; Kerr SJ; Iampornsin T; Pett SL; Avihingsanon A; Thongpaeng P; Zaunders JJ; Ubolyam S; Ananworanich J; Kelleher AD; Cooper DA, 2013, 'Restoration of CMV-Specific-CD4 T Cells with ART Occurs Early and Is Greater in Those with More Advanced Immunodeficiency', PLoS ONE, vol. 8, http://dx.doi.org/10.1371/journal.pone.0077479

Tu E; Swenson LC; Land S; Pett S; Emery S; Marks K; Kelleher AD; Kaye S; Kaiser R; Schuelter E; Harrigan R, 2013, 'Results of external quality assessment for proviral DNA testing of HIV tropism in the Maraviroc switch collaborative study', Journal of Clinical Microbiology, vol. 51, pp. 2063 - 2071, http://dx.doi.org/10.1128/JCM.00510-13

Davey Jr R; Lynfield R; Dwyer DE; Losso MH; Cozzi-Lepri A; Wentworth D; Lane HC; Dewar RL; Pett SL; Uyeki TM; Angus BJ; Cummins NW; Lundgren JD; Neaton JD, 2013, 'The Association between Serum Biomarkers and Disease Outcome in Influenza A(H1N1)pdm09 Virus Infection: Results of Two International Observational Cohort Studies', PLoS ONE, vol. 8, pp. e57121, http://dx.doi.org/10.1371/journal.pone.0057121

Leenders FJ; Amin J; Bloch M; Pett SL; Marriott D; Carr AD, 2013, 'Skeletal muscle toxicity associated with raltegravir-based combination antiretroviral therapy in HIV-infected adults', JAIDS: Journal of Acquired Immune Deficiency Syndromes, vol. 62, pp. 525 - 533, http://dx.doi.org/10.1097/QAI.0b013e3182832578

Bjerk SM; Baker J; Emery S; Neuhaus JA; Angus BJ; Gordin F; Pett SL; Stephan C; Kunisaki KM, 2013, 'Biomarkers and Bacterial Pneumonia Risk in Patients with Treated HIV Infection: A Case-Control Study', PLoS ONE, vol. 8, pp. e56249, http://dx.doi.org/10.1371/journal.pone.0056249

Hsu DC; Zaunders J; Plit ML; Leeman C; Ip S; Iampornsin T; Pett SL; Bailey MR; Amin J; Ubolyam S; Avihingsanon A; Ananworanich J; Ruxrungtham K; Cooper DA; Kelleher AD, 2012, 'A novel assay detecting recall response to Mycobacterium tuberculosis: Comparison with existing assays', Tuberculosis, vol. 92, pp. 321 - 327, http://dx.doi.org/10.1016/j.tube.2012.03.008

Botes LP; Pett SL; Carr AD; Marriott D; Cooper DA; Matthews G; Carbone S; Kumaradevan N; Mchugh L; Hillman R, 2012, 'Anal cytological abnormalities are poor predictors of high-grade intraepithelial neoplasia amongst HIV-positive men who have sex with men.', Sexual Health, vol. 10, pp. 9 - 17, http://dx.doi.org/10.1071/SH11135

Carey DL; Pett SL; Bloch M; Wand H; MacRae K; Beileiter K; Ray J; Boyd MA; Emery S; Cooper DA, 2012, 'A randomized study of pharmacokinetics, efficacy, and safety of 2 raltegravir plus atazanavir strategies in ART-treated adults', JAIDS: Journal of Acquired Immune Deficiency Syndromes, vol. 60, pp. 143 - 149, http://dx.doi.org/10.1097/QAI.0b013e318252f97e

Boesecke C; Pett SL, 2012, 'Clinical studies with chemokine receptor-5 (CCR5)-inhibitors', Current opinion in HIV & AIDS, vol. 7, pp. 456 - 462, http://dx.doi.org/10.1097/COH.0b013e328356e933

Babiker AG; Emery S; Faetkenheuer G; Gordin FM; Grund B; Lundgren JD; Neaton JD; Pett SL; Phillips A; Touloumi G; Vjecha MJ, 2012, 'Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study', CLINICAL TRIALS, pp. 1 - 32, http://dx.doi.org/10.1177/1740774512440342

Hillman R; Pett SL; Marriott D; Carr AD; Cooper DA; Matthews GV; Brew BJ; Milliken S; Botes LP, 2011, 'Participants' perspectives of high resolution anoscopy', Sexual Health, vol. 8, pp. 255 - 256, http://dx.doi.org/10.1071/SH10116

Botes LP; Jin F; Bourne CP; Pett SL; Marriott D; Carr AD; Cooper DA; Matthews G; Brew BJ; Hillman R, 2011, 'Participants' perspectives of self-collected anal cytological swabs', Sexual Health, vol. 8, pp. 257 - 258, http://dx.doi.org/10.1071/SH10037

Wallace BJ; Tan KB; Pett SL; Cooper DA; Kossard S; Whitfeld M, 2011, 'Enfuvirtide injection site reactions: A clinical and histopathological appraisal', Australasian Journal of Dermatology, vol. 52, pp. 19 - 26, http://dx.doi.org/10.1111/j.1440-0960.2010.00717.x

Pett SL; Carey C; Lin E; Wentworth D; Lazovski J; Miro J; Gordin F; Angus B; Rodriguez-Barradas M; Rubio R; Tambussi G; Cooper DA; Emery S, 2011, 'Predictors of bacterial pneumonia in Evaluation of Subcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT)', HIV Medicine, vol. 12, pp. 219 - 227, http://dx.doi.org/10.1111/j.1468-1293.2010.00875.x

Dwyer DE; Davey R; Losso MH; Lynfield R; Cozzi-Lepri A; Gey D; Herman-Lamin K; Hoppe A; Lane ; Lundgren JD; Neaton JD; Pett SL; Standridge B; Uyeki M; Wentworth D, 2011, 'Surveillance of illness associated with pandemic (H1N1) 2009 virus infection among adults using a global clinical site netwok approach: The INSIGHT FLU 002 and FLU 003 studies', Vaccine, vol. 29, pp. B56 - B62, http://dx.doi.org/10.1016/j.vaccine.2011.04.105

Pett SL; Kelleher AD; Emery S, 2010, 'Role of interleukin-2 inpatients with HIV infection', Drugs, vol. 70, pp. 1115 - 1130, http://dx.doi.org/10.2165/10898620-000000000-00000

Neuhaus J; Jacobs DR; Baker JV; Calmy A; Duprez D; La Rosa A; Kuller LH; Pett SL; Ristola M; Ross M; Shlipak MG; Tracy R; Neaton JD, 2010, 'Markers of inflammation, coagulation and renal function are elevated in adults with HIV infection', Journal of Infectious Diseases, vol. 201, pp. 1788 - 1795, http://dx.doi.org/10.1086/652749

Pett SL; Zaunders J; Bailey M; Murray JM; Macrae K; Emery S; Cooper DA; Kelleher AD, 2010, 'A novel Chemokine-Receptor-5 (CCR5) blocker, SCH532706, has differential effects on CCR5+CD4+ and CCR5+CD8+ T cell numbers in chronic HIV infection', AIDS Research and Human Retroviruses, vol. 26, pp. 653 - 661, http://dx.doi.org/10.1089/aid.2009.0278

Pett SL; Emery S; Kelleher AD; Cooper DA, 2010, 'Antiretroviral agents: Focus on maraviroc for the treatment of HIV-1-infected adults', Clinical Medicine Insights: Therapeutics, vol. 2, pp. 697 - 713, http://www.la-press.com/

Zaunders J; Munier ML; Seddiki N; Pett SL; Ip S; Bailey M; Xu Y; Brown KJ; Dyer W; Kim MS; De Rose R; Kent SJ; Jiang L; Breit SN; Emery S; Cunningham AL; Cooper DA; Kelleher AD, 2009, 'High levels of human antigen-specific CD4+ T cells in peripheral blood revealed by stimulated coexpression of CD25 and CD134 (OX40)', Journal of Immunology, vol. 183, pp. 2827 - 2836, http://dx.doi.org/10.4049/jimmunol.0803548

Seddiki N; Sasson SC; Santner-Nanan B; Munier M; Van Bockel DJ; Ip S; Marriott D; Pett SL; Nanan R; Cooper DA; Zaunders J; Kelleher AD, 2009, 'Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease', European Journal of Immunology, vol. 39, pp. 391 - 403, http://dx.doi.org/10.1002/eji.200838630

Pett SL; Mccarthy M; Cooper DA; MacRae K; Tendolkar A; Norris R; Strizki J; Williams KM; Emery S, 2009, 'A Phase I study to explore the activity and safety of SCH532706, a small molecule chemokine receptor-5 antagonist in HIV type-1-infected patients', Antiviral Therapy, vol. 14, pp. 111 - 115

Pett SL, 2009, 'Immunotherapies in HIV-1 infection', Current opinion in HIV & AIDS, vol. 4, pp. 188 - 193, http://dx.doi.org/10.1097/COH.0b013e328329d090

Boyd MA; Pett SL, 2008, 'Experimental and clinical pharmacology - HIV fusion inhibitors: a review', Australian Prescriber, vol. 31, pp. 66 - 69, http://dx.doi.org/10.18773/austprescr.2008.040

Dyer W; Pett SL; Sullivan JS; Emery S; Cooper DA; Kelleher AD; Lloyd AR; Lewin S, 2007, 'Substantial improvements in performance indicators achieved in a peripheral blood mononuclear cell cryopreservation quality assurance program using single donor samples', Clinical and Vaccine Immunology, vol. 14, pp. 52 - 59, http://dx.doi.org/10.1128/CVI.00214-06

Pett SL; Wand HC; Law MG; Arduino R; Lopez JC; Knysz B; Pereira L; Pollack S; Reiss P; Tambussi G, 2006, 'Evaluation of subcutaneous proleukin (interleukin-2) in a randomized international trial (ESPRIT): Geographical and gender differences in the baseline characteristics of participants', HIV Clinical Trials, vol. 7, pp. 70 - 85, http://dx.doi.org/10.1310/4733-ACQF-F3P4-2QAC

Lifson A; Rhame F; Belloso WH; Dragsted U; El-Sadr W; Gatell J; Hoy JF; Krum E; Nelson R; Pedersen C; Pett SL; Davey R, 2006, 'Reporting and evaluation of HIV-related clinical endpoints in two multicenter international clinical trials', HIV Clinical Trials, vol. 7, pp. 125 - 141, http://dx.doi.org/10.1310/7MER-XFA7-1762-E2WR

Stark D; Pett SL; Marriott D; Harkness JL, 2006, 'Post-kala-azar dermal leishmaniasis due to Leishmania infantum in a human immunodeficiency virus type 1-infected patient', Journal of Clinical Microbiology, vol. 44, pp. 1178 - 1180, http://dx.doi.org/10.1128/JCM.44.3.1178-1180.2006

Samaras K; Pett SL; Gowers A; McMurchie M; Cooper DA, 2005, 'Iatrogenic Cushing`s syndrome with osteoporosis and secondary adrenal failure in human immunodeficiency virus-infected patients receiving inhaled corticosteroids and ritonavir-boosted protease inhibitors: Six cases', Journal of Clinical Endocrinology and Metabolism, vol. 90, pp. 4394 - 4398, http://dx.doi.org/10.1210/jc.2005-0036

Pett SL; Kelleher A, 2004, 'Antiretroviral therapy-induced immune restoration in HIV infection: A double-edged sword?', Expert Review of Anti-Infective Therapy, vol. 2, pp. 335 - 339, http://dx.doi.org/10.1586/14787210.2.3.335

Pett SL; Williams LA; Day RO; Lloyd AR; Carr AD; Clezy KR; Emery S; Kaplan E; Mcphee D; Mclachlan AJ; Gelder F; Lewin S; Liauw WS; Williams KM, 2004, 'A phase I study of the pharmacokinetics and safety of passive immunotherapy with caprine anti-HIV antibodies, (PE)HRG214, in HIV-1-infected individuals', HIV Clinical Trials, vol. 5, pp. 91 - 98, http://dx.doi.org/10.1310/1FLN-8KFC-5HEQ-K19J

Pett SL; Kelleher AD, 2003, 'Cytokine therapies in HIV-1 infection: Present and future', Expert Review of Anti-Infective Therapy, vol. 1, pp. 83 - 96, http://dx.doi.org/10.1586/14787210.1.1.83

Pett SL; Kelleher AD, 2003, 'Cytokine therapies in HIV-1 infection: present and future', Expert Review of Anti-Infective Therapy, vol. 1, pp. 89 - 102

O Loughlin AJ; Pett SL; Anderson D; Yorke J; Chua R; Williams DB; Hayward CS; Keogh AM; Macdonald PS; Cunningham PH, 2003, 'Cytomegalovirus polymerase chain reaction tests can replace endoscopy and biopsy for the initial diagnosis of cytomegalovrius gastrointestinal disease in patients following heart transplantation', CSANZ

Pett SL; Dore GJ; Fielden R; Cooper DA, 2002, 'Cyclical hepatitis and early liver cirrhosis after hepatitis C seroconversion during pulsed antiretroviral therapy for primary HIV-1', AIDS, vol. 16, pp. 2364 - 2365, http://dx.doi.org/10.1097/00002030-200211220-00029

Pett SL; Emery S, 2001, 'Immunomodulators as adjunctive therapy for HIV-1 infection', Journal of Clinical Virology, vol. 22, pp. 289 - 295, http://dx.doi.org/10.1016/S1386-6532(01)00201-3

Suzuki K; Cunningham P; Harris C; Leas L; Zaunders J; Cooper DA; Kaufmann GR; Pett SL; Kelleher A; Mukaide M; Imai M; Kondo M; Finlayson R, 2001, 'Novel deletion of HIV type 1 reverse transcriptase residue 69 conferring selective high-level resistance to nevirapine', AIDS Research and Human Retroviruses, vol. 17, pp. 1293 - 1296, http://dx.doi.org/10.1089/088922201750461366

Pett SL; Milliken S, 2000, 'Current review of the metabolic and endocrine disturbances in human immunodeficiency virus infection', Current Opinion in Endocrinology and Diabetes, vol. 7, pp. 96 - 101, http://dx.doi.org/10.1097/00060793-200004000-00009